July 12, 2017Webinar

Update on Biosimilars Litigation

In this webinar, attorney Andrew Dufresne will explore the Supreme Court’s Amgen v. Sandoz decision and its implications for litigation under the fledgling biosimilars regime in the United States. The presentation will also include an update on emerging trends in biosimilars litigation.

We will apply for CLE credit in WI, IL, TX, UT, and VA (if applicable).

To view past recordings, please visit our Life Sciences Webinar Series Library.

Time: 12:00 - 1:00 p.m. (Central)
Complimentary Live Webinar

back to top